FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells. - Wikidata - wikimedia - TriplyDB

FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.

FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.

http://www.wikidata.org/entity/Q39564479

about

O-GlcNAcylation regulates EZH2 protein stability and function EZH2 methyltransferase and H3K27 methylation in breast cancer Targeting EZH2 in cancer Polycomb group expression signatures in the malignant progression of gliomas.EZH2: not EZHY (easy) to deal.Functional and therapeutic significance of EZH2 in urological cancers Regulation and Role of EZH2 in Cancer ATRA inhibits the proliferation of DU145 prostate cancer cells through reducing the methylation level of HOXB13 gene.YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK miR-639 regulates transforming growth factor beta-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting FOXC1.PRC2 regulates RNA polymerase III transcribed non-translated RNA gene transcription through EZH2 and SUZ12 interaction with TFIIIC complex.The forkhead box transcription factor FOXC1 promotes breast cancer invasion by inducing matrix metalloprotease 7 (MMP7) expression.Epithelial cell identity in hyperplastic precursors of breast cancer.β2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion.BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC.Multifaceted role of EZH2 in breast and prostate tumorigenesis: epigenetics and beyond.Canonical and non-canonical roles of the histone methyltransferase EZH2 in mammary development and cancer.Optimized Method for Untargeted Metabolomics Analysis of MDA-MB-231 Breast Cancer Cells Pan-cancer patterns of somatic copy number alteration.EZH2 participates in malignant biological behavior of epithelial ovarian cancer through regulating the expression of BRCA1.FOXC1 promotes proliferation and epithelial-mesenchymal transition in cervical carcinoma through the PI3K-AKT signal pathway.EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis.EZH2, an epigenetic driver of prostate cancer.Epigenetic mechanisms of breast cancer: an update of the current knowledge.Foxj2 overexpression is associated with poor prognosis, progression, and metastasis in nasopharyngeal carcinoma.MiR-138: A promising therapeutic target for cancer.EZH2 inhibitors: a patent review (2014-2016).Genome-wide transcriptional profiling analysis reveals annexin A6 as a novel EZH2 target gene involving gastric cellular proliferation.Overexpression of forkhead box J2 can decrease the migration of breast cancer cells.High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer.FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles.The transcription factor Foxc1a in zebrafish directly regulates expression of nkx2.5, encoding a transcriptional regulator of cardiac progenitor cells.Downregulation of FOXP2 promoter human hepatocellular carcinoma cell invasion.MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1.High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma.Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells.Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling

P2860

Q24324113-359FA403-CB34-4BDE-BC4A-F78AF54D8A75 Q24633788-959FD052-B2DA-41DF-81D4-8F91F595F72A Q26769027-270D04B7-2EEB-406F-8386-DDAEFB7EBE5E Q33599449-13B70278-9AD3-4F78-BCA9-9BC45C78AD0A Q33610902-C211724C-45A6-4E9D-A5EF-F4EA86E51CC1 Q33914244-8B681E89-D732-420A-9734-AD8E8A536E44 Q34043370-5B25EE99-106F-4D1A-BFA5-FBD9714E24AC Q34342517-B7694D18-EDEB-4C57-89FD-E4AEFA131DF1 Q34571374-A384ED1C-4E5E-480E-BE15-EB742C004A58 Q35713143-4A19E234-E57C-4E15-A413-4363A92D6580 Q35885921-3E4749BC-874E-4B96-917B-8A19188945E4 Q36098052-7462D30F-F727-4AC6-A9C9-D2FABADB02EB Q36121103-0DCB2D02-4D60-4361-9E83-E437F911019A Q36321486-535A997F-A484-4A33-A1B8-5AD54937BCFB Q36432043-9307F633-7E25-4955-91A1-5849FC40F8D1 Q36545265-E5C3A2AB-57E5-4515-9034-F9CEE88B4877 Q37089496-1A4E8A9A-3F1A-494E-A48E-6E6B30822322 Q37350954-86D45DBE-0831-43A5-BCF7-F3E1D87F2411 Q37539364-78AC9E1E-1B25-4CCB-80BF-EE95C16BE2C7 Q37666205-8854EA23-0B0F-4955-A7CF-030D87D91254 Q37683036-80B55ED7-A4FF-4AE7-9B7E-6F921DD68705 Q37733027-33EF2333-E3ED-4754-AC44-4B9E3E7D6969 Q38019814-CE8A003A-85F4-4AFC-8E50-377102C41DA6 Q38103472-5E9A917E-B8A5-43B7-A3FD-0FCCF89452FD Q38296760-2858FD60-B971-4F8E-95DF-6313C00EC7CF Q38645797-3A0E0F7C-D345-48FA-B713-806BE021DFBC Q38734800-A083C47C-6487-423E-ABC7-86B69EC2EA1E Q38844652-AB0B1DA6-56C5-45A7-847A-BA5AD9C00AB8 Q38878459-8A235205-A17E-4ADD-B5FB-1CB105A2C31C Q39375100-0B9EC7AA-06AD-4E4E-B616-64337FE30BB2 Q44208783-8645ECD0-807D-41F2-B184-307C78FB4E84 Q47295917-B30ECACA-0202-4AEB-AA35-203B3AD306B4 Q49624286-9F47FC93-1E5E-4E4A-80C8-3C42BD2EB92E Q49834130-278FC4D8-D261-4120-AA21-AE6B781E38E4 Q53440458-691088B8-0918-444F-BDF5-BAB4620F98FF Q53542144-65F3E4D9-A5BC-442D-9E47-1904078D0BFF Q54279370-C2A33518-B34D-4C95-A2B9-0D3F8A2A8189 Q55131833-B432BC10-8323-409F-98F3-AB3FB98B0C9F Q58704446-66D6DD63-908F-4232-9577-C24C28E08F9C

P2860

FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.

http://www.wikidata.org/entity/Q39564479

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.

@en

FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.

@nl

type

label

FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.

@en

FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.

@nl

prefLabel

FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.

@en

FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.

@nl

P1433

Q39564479-27D73B71-CEE8-4932-AEDB-AD13A5A7F61D

P1476

Q39564479-59E5E835-AFA1-4476-A1AB-4BC59910CA48

P2093

Q39564479-043EB4B5-F0AE-4AB4-A708-8F8C7EEFA351

Q39564479-06C97A5A-D3CE-45B0-BF65-9B3F32DA948E

Q39564479-0DB4DFBC-B88C-43CB-BD4E-613BE89CD456

Q39564479-1E3B7B8D-0E94-4E5A-A5D4-E208689293F5

Q39564479-1EBBC1CC-FD51-4B4A-A9D1-5FC719975BAC

Q39564479-2248BB9D-CAB6-4423-AC7B-397765487DEC

Q39564479-46C65F47-B97A-40F8-B6EC-80D6AC8B2410

Q39564479-7AE39FD7-06C2-4889-B1E5-4FCBB307B1DE

Q39564479-CE25B1E3-8778-48F3-B0E8-F56B075E213F

Q39564479-E0AD8F87-512A-44B9-AAF9-35F6E210B717

P2860

Q39564479-01D3F56A-4661-4094-A7D9-BBB88546666B

Q39564479-09C4F9DE-21A6-4792-8B88-A8E9B1142127

Q39564479-0A5CE7D1-1E19-4285-BD39-4B7DEC968BCC

Q39564479-0B9F008B-8421-4F9B-9B9A-50AE1ECB856C

Q39564479-1C54FE48-058B-4FBF-93FF-9D6D917C3D28

Q39564479-1C708FE7-5E4F-4173-9DE2-944C7E3F2973

Q39564479-24C6B0F4-3959-4533-B33C-D778162B3414

Q39564479-25BF7FD2-D1B0-4AD6-89A8-CD3F4DF3E362

Q39564479-2CEBEC7E-DD69-4169-A5E5-5776EE56321A

Q39564479-2E24F885-3AE2-4FA0-9C0D-3CD24BB11EAC

P2888

Q39564479-3C8F98FD-D8AE-4845-877D-6DF2BD7776BA

P304

Q39564479-A90CACBA-69A8-4A2E-B221-8F77D6CA8947

P31

Q39564479-D21FBE53-1C0F-4647-A2D5-D4D94672A114

P356

Q39564479-636C44A9-3210-47CC-AC35-08D494F1B46F

P407

Q39564479-C609A56A-13F8-489E-AE3F-0280CC813ECC

P433

Q39564479-EE968EE5-3BA3-424D-B71F-0BB6E17B6DE3

P478

Q39564479-A9527B52-01BA-4E9F-A2F8-4E7050ABB0AD

P577

Q39564479-9E094833-C38F-4B13-B31E-2EF4A8627C95

P5875

Q39564479-7B171D28-1C40-4E99-8B4E-D84C18023FCE

P698

Q39564479-C94B5177-3A19-4EF8-8FBF-0950B9721DE0

P356

S10549-011-1396-3

P1433

Breast Cancer Research and Treatment

P1476

FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.

@en

P2093

Baiqu Huang

http://www.w3.org/2001/XMLSchema#string

Chenfei Kong

http://www.w3.org/2001/XMLSchema#string

Hao Jiang

http://www.w3.org/2001/XMLSchema#string

Juan Du

http://www.w3.org/2001/XMLSchema#string

Jun Lu

http://www.w3.org/2001/XMLSchema#string

Lin Li

http://www.w3.org/2001/XMLSchema#string

Shan Zhu

http://www.w3.org/2001/XMLSchema#string

Yu Zhang

http://www.w3.org/2001/XMLSchema#string

Zhimin Shao

http://www.w3.org/2001/XMLSchema#string

Zhixiong Dong

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of FOXC1 as a TGF-beta1 responsive gene and its involvement in negative regulation of cell growth

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers

Epithelial-mesenchymal transitions in tumour progression

Role of histone H3 lysine 27 methylation in Polycomb-group silencing

The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer

The evolution of Fox genes and their role in development and disease

FOXC1 is required for normal cerebellar development and is a major contributor to chromosome 6p25.3 Dandy-Walker malformation

Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions

Polycomb silencers control cell fate, development and cancer

P2888

s10549-011-1396-3

P304

65-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-011-1396-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51000390

http://www.w3.org/2001/XMLSchema#string

P698

21465172

http://www.w3.org/2001/XMLSchema#string